Novartis wants Japan to link drug price to patient outcomes

to The Nikkei in a recent interview. Japan has never implemented such a payment scheme. At issue is Kymriah, a new treatment for acute lymphoblastic leukemia in children and young adults. Kymriah in August became the first CAR-T cell therapy — one that …
( read original story …)


Related Post

Yokohama Names New Ambassador
views 215
Founder of Ice Driving Canada named Yokohama&rsquo...
Mitsubishi UFJ Financial : Bank Of Tokyo-Mitsubish...
views 207
TOKYO (dpa-AFX) - The U.S. Commodity Futures Tradi...
Nikkei rises as dollar-yen steady; activity thin b...
views 172
TOKYO, Aug 25 (Reuters) - Japan's Nikkei share ave...
Japan unveils prototype wheeled armoured vehicle, ...
views 193
... type to replace the Type 96 eight-wheel drive ...
Interview: Abe's attempts to revise Constitut...
views 228
A recent poll by Japan's Kyodo News showed that 51...
Trump lands in Japan, says U.S. and allies are pre...
views 192
KAWAGOE, Japan (Reuters) - U.S. President Donald T...
What happened to Wei Qiujie, the Chinese teacher m...
views 184
WEI Qiujie was only meant to be in Japan for a wee...
Light earthquake 4.1 mag, 10 km W of Shizuoka-shi,...
views 32
A light earthquake magnitude 4.1 (ml/mb) strikes 1...
US Open: Naomi Osaka beats Serena Williams in cont...
views 20
Osaka went on to hold that game to love and broke ...
Typhoon brings heavy rain, powerful winds to weste...
views 26
Prime Minister Shinzo Abe cancelled a scheduled tr...